IX Biopharma Company Announcements (42C)

SGX Google Yahoo News TradingView

IX BIOPHARMA LTD. (42C) SGD 0.047 +4.26% +0.00

Portfolio Watchlist

All Financial Buy Back Insider Trading

2019-03-29

Change - Announcement of Appointment::Appointment of Chief Operating Officer

2019-03-17

Asset Acquisitions and Disposals::PROPOSED DISPOSAL OF LABORATORY TESTING BUSINESS

2019-02-17

Asset Acquisitions and Disposals::PROPOSED DISPOSAL OF LABORATORY TESTING BUSINESS

2019-02-11

Financial Statements and Related Announcement::Second Quarter and/ or Half Yearly Results

2018-12-14

Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN

2018-11-30

REPL::Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN

2018-11-16

Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN

2018-11-16

Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN

2018-11-12

General Announcement::CHANGES IN THE COMPOSITION OF THE BOARD AND REMUNERATION COMMITTEE

2018-11-12

Financial Statements and Related Announcement::First Quarter Results

2018-11-06

REPL::General Announcement::IX BIOPHARMA TO PRESENT WAFERMINE PHASE 2 STUDY RESULTS

2018-11-05

General Announcement::IX BIOPHARMA TO PRESENT WAFERMINE PHASE 2 STUDY RESULTS

2018-10-19

Change - Announcement of Cessation::Retirement of Lead Independent Director

2018-10-19

REPL::Annual General Meeting::Voluntary

2018-09-26

Annual Reports and Related Documents::

2018-09-26

Annual General Meeting::Voluntary

2018-09-21

General Announcement::UPDATE ANNOUNCEMENT ON PROPOSED SILDENAFIL RECLASSIFICATION

2018-09-05

General Announcement::IX BIOPHARMA REPORTS POSITIVE RESULTS FROM WAFERMINE PHASE 2 MULTI-DOSE CLINICAL EFFICACY TRIAL

2018-08-27

Financial Statements and Related Announcement::Full Yearly Results

2018-08-06

General Announcement::APPROVAL OF FIRST CAPSULE SILDENAFIL DRUG FOR TREATMENT OF MALE ERECTILE DYSFUNCTION IN AUSTRALIA

2018-06-25

General Announcement::CHANGE IN USE OF IPO PROCEEDS

2018-06-19

General Announcement::IX BIOPHARMA OBTAINS APPROVAL & REGISTRATION OF WAFESIL FOR TREATMENT OF MALE ERECTILE DYSFUNCTION

2018-06-12

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities

2018-05-09

Financial Statements and Related Announcement::Third Quarter Results

2018-04-18

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities

2018-04-18

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities

2018-04-05

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2018-03-12

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities

2018-03-08

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Eddy Lee Yip Hang

2018-02-08

General Announcement::IX BIOPHARMA SECURES CHINA PATENT FOR WAFERIX DRUG DELIVERY TECHNOLOGY

2018-02-08

Financial Statements and Related Announcement::Second Quarter and/ or Half Yearly Results

2018-01-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2018-01-04

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities

2017-11-20

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2017-11-10

Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN

2017-11-10

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification in Respect of Changes in Interest of a Director - Eddy Lee Yip Hang

2017-11-10

Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN

2017-11-08

General Announcement::Establishment of A Risk Management Committee

2017-11-08

Financial Statements and Related Announcement::First Quarter Results

2017-10-24

General Announcement::Responses to SIAS' Questions on iX Biopharma's Annual Report FY2017

2017-10-24

REPL::Extraordinary/ Special General Meeting::Voluntary

2017-10-24

REPL::Annual General Meeting::Voluntary

2017-10-23

General Announcement::iX Biopharma Secures European Patent for WaferiX Drug Delivery Technology

2017-09-27

Extraordinary/ Special General Meeting::Voluntary

2017-09-27

Annual Reports and Related Documents::

2017-09-27

Annual General Meeting::Voluntary

2017-08-23

Financial Statements and Related Announcement::Full Yearly Results

2017-05-15

General Announcement::iX Biopharma Launches New Supplements Business Arm

2017-05-14

General Announcement::iX Biopharma Reports Positive Results from Pharmacokinetic Study of BnoX

2017-05-11

Financial Statements and Related Announcement::Third Quarter Results

© 2023 Dividends.sg / More Countries